| CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
| 50302-74-4 | | 2-butanone, 4-(6-phenyl-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2':1,6)pyrido(3 | | | | |
| 50302-75-5 | | 2-butanone, 4-(6-methyl-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2':1,6)pyrido(3 | | | | |
| 50302-76-6 | | pyrazino(1',2':1,6)pyrido(3,4-b)indole, 1,2,3,4,6,7,12,12a-octahydro-2-(2-(4-py | | | | |
| 50302-77-7 | | pyrazino(1',2':1,6)pyrido(3,4-b)indole, 1,2,3,4,6,7,12,12a-octahydro-6-methyl-2 | | | | |
| 50304-44-4 | | p(1),p(5)-di(adenosine-5'-)pentaphosphate | | | | |
| 503045-59-8 | | 6-chloro-3-iodo-1h-indazole | | | | |
| 50305-28-7 | | z-trp-osu | C23H21N3O6 | 435.43 | | |
| 50305-43-6 | | boc-his(z)-oh | CH23N3O6 | 173.21 | | |
| 50305-74-3 | | methyl 3-oxo-5-beta-androstane-17-beta-carboxylate | | | | |
| 50305-81-2 | | cholesterolcinnamate | | | | |
| 50306-58-6 | | lithium tri-tert-butoxyaluminodeuteride | | | | |
| 503068-34-6 | 维兰特罗 | vilanterol | | | | |
| 503068-36-8 | (R)-3-(6-(2-((2,6-二氯苄基)氧基)乙氧基)己基)-5-(2,2-二甲基-4h-苯并[d] [1,3]二噁英-6-基)噁唑烷-2-酮 | (R)-3-(6-(2-((2,6-dichlorobenzyl)oxy)ethoxy)hexyl)-5-(2,2-dimethyl-4h-benzo[d][1,3]dioxin-6-yl)oxazolidin-2-one | | | | |
| 503070-57-3 | 1,3-二氯-2-[[2-[(6-溴己基)氧基]乙氧基]甲基]苯 | 2-[[2-[(6-bromohexyl)oxy]ethoxy]methyl]-1,3-dichlorobenzene | | | | |
| 503070-58-4 | 维兰特罗三苯乙酸盐 | vilanteroltrifenatate | | | | |
| 503072-28-4 | | 1-boc-2-cbz-4-methylene-pyrazolidine | | | | |
| 503072-63-7 | | 1-benzyl 2-tert-butyl 4-oxopyrazolidine-1,2-dicarboxylate | | | | |
| 50308-82-2 | | quinolinium, 6-chloro-1-methyl-4-(p-((p-((1-methylpyridinium-4-yl)amino)phenyl) | | | | |
| 50308-83-3 | | quinolinium, 7-chloro-1-methyl-4-(p-((p-((1-methylpyridinium-4-yl)amino)phenyl) | | | | |
| 50308-84-4 | | quinolinium, 8-chloro-1-methyl-4-(p-((p-((1-methylpyridinium-4-yl)amino)phenyl) | | | | |
| 50308-86-6 | | quinolinium, 1,3-dimethyl-4-(p-((p-((1-methylpyridinium-4-yl)amino)phenyl)carba | | | | |
| 50308-87-7 | | quinolinium, 1,6-dimethyl-4-(p-((p-((1-methylpyridinium-4-yl)amino)phenyl)carba | | | | |
| 50308-88-8 | | quinolinium, 6-methoxy-1-methyl-4-(p-((p-((1-methylpyridinium-4-yl)amino)phenyl | | | | |
| 50308-89-9 | | quinolinium, 8-methoxy-1-methyl-4-(p-((p-((1-methylpyridinium-4-yl)amino)phenyl | | | | |
| 50308-94-6 | | quinolinium, 6-amino-1-methyl-4-((4-((((1-methylpyridinium-4-yl)amino)phenyl)ca | | | | |
| 50308-97-9 | | quinolinium, 7-amino-1-methyl-4-(p-((p-((1-methylpyridinium-4-yl)amino)phenyl)c | | | | |
| 50309-00-7 | | quinazolinium, 6-amino-1-methyl-4-((4-(((4-((1-methylpyridinium-4-yl)amino)phen | | | | |
| 50309-01-8 | | quinolinium, 4-((4-(((4-(2,4-diamino-1-methylpyrimidinium-5-yl)phenyl)amino)car | | | | |
| 50309-02-9 | | quinolinium, 4-((4-(((4-(2,4-diamino-1-ethylpyrimidinium-5-yl)phenyl)amino)carb | | | | |
| 50309-03-0 | | quinolinium, 4-((4-(((4-(2,4-diamino-1-propylpyrimidinium-5-yl)phenyl)amino)car | | | | |
| 50309-07-4 | | 4-((p-(p-acetylphenyl)carbamoyl)anilino)-6-amino-1-methyl-quinoliniu p-amid | | | | |
| 50309-09-6 | | 4-((p-(p-acetylphenyl)carbamoyl)anilino)-1-methyl-7-nitro-quinoliniu p-amid | | | | |
| 50309-10-9 | | 4-((p-(p-acetylphenyl)carbamoyl)anilino)-7-amino-1-methyl-quinoliniu p-amid | | | | |
| 50309-11-0 | | quinolinium, 1-methyl-4-(p-(p-((1-methylpyridinium-4-yl)amino)benzamido)anilino | | | | |
| 50309-15-4 | | quinolinium, 6-amino-1-methyl-4-(p-(p-((1-methylpyridinium-4-yl)amino)benzamido | | | | |
| 50309-16-5 | | quinolinium, 6-amino-1-ethyl-4-(p-(p-((1-ethylpyridinium-4-yl)amino)benzamido)a | | | | |
| 50309-17-6 | | quinolinium, 1-methyl-4-(p-((p-((1-methylpyridinium-4-yl)amino)phenyl)carbamoyl | | | | |
| 50309-18-7 | | quinolinium, 7-amino-1-methyl-4-(p-(p-((1-methylpyridinium-4-yl)amino)benzamido | | | | |
| 50309-20-1 | | quinolinium, 7-acetamido-1-methyl-4-(p-(p-((1-methylpyridinium-4-yl)amino)benza | | | | |
| 50309-23-4 | | 4-(p-(p-acetylbenzamido)anilino)-6-amino-1-methyl-quinoliniu p-amidinohydra | | | | |
| 50309-27-8 | | quinolinium, 6-amino-1-methyl-4-(p-(p-((1-methylpyridinium-4-yl)amino)styryl)an | | | | |
| 50309-29-0 | | quinolinium, 6-amino-1-methyl-4-(p-((p-((1-methylpyridinium-4-yl)amino)phenyl)u | | | | |
| 50309-32-5 | | 4-(p-((p-acetylphenyl)ureylene)anilino)-6-amino-1-methyl-quinoliniu p-amidi | | | | |
| 50309-35-8 | | quinolinium, 6-amino-1-methyl-4-((4-(3-((4-((1-methylpyridinium-4-yl)amino)phen | | | | |
| 50309-45-0 | | 5-ethyl-1-(morpholinomethyl)-5-phenyl-barbituric aci hydrochloride | | | | |
| 50309-46-1 | | 3,5,7-triaza-1-azoniatricyclo(3.3.1.1(sup 3,7))decane, 1,1'-((5-ethyldihydro-2, | | | | |
| 50309-47-2 | | 1,3-bis(2-isothioureidomethyl)-5-ethyl-5-phenyl-barbituric aci dihydrobromi | | | | |
| 50309-48-3 | | carbamimidothioic acid, phenyl-, (5-ethyldihydro-2,4,6-trioxo-5-phenyl-1,3(2h,4 | | | | |
| 50309-49-4 | | 1-((amidinothio)methyl)-5-ethyl-3-methyl-5-phenyl-barbituric aci monohydrob | | | | |
| 503090-99-1 | 纳曲酮ep杂质h | naltrexone ep impurity h | | | | |
m.cnreagent.com